Novo’s development chief, Martin Holst Lange, has shown optimism about the drug’s promise, though he refrained from making any guarantees.
read more Read More
Posted inBusiness & Finance
Novo’s development chief, Martin Holst Lange, has shown optimism about the drug’s promise, though he refrained from making any guarantees.
read more Read More